drug costs

News

Cost-Sharing Patterns for PARP Inhibitor Therapy in Ovarian Cancer

02/12/2021

Journal of Clinical Pathways

News

Total and Out-of-Pocket Costs of PARP Inhibitor Therapy for Ovarian Cancer

01/21/2021

Journal of Clinical Pathways

News

Feasibility of an Oral Oncology Drug Repository Program

01/05/2021

Journal of Clinical Pathways

Conference Coverage

Cost-Effectiveness Comparison of BTK Inhibitors for MCL

12/09/2020

Journal of Clinical Pathways

News

Comparison of Costs, Outcomes Among Neoadjuvant-Adjuvant Treatment Strategies for Breast Cancer

12/08/2020

Journal of Clinical Pathways

Conference Coverage

Comparison of HCRU and Costs Associated With Treatments for Relapsed/Refractory DLBCL

12/06/2020

HCRU and costs associated with CAR-T therapy were greater than transplantation for DLBCL and cost offsets before and after the procedures provide useful insight for treatment planning.

HCRU and costs associated with...

12/06/2020

Journal of Clinical Pathways

Conference Coverage

Polatuzumab Vedotin Plus Bendamustine-Rituximab Cost-Effective for DLBCL

12/05/2020

Journal of Clinical Pathways

Conference Coverage

Treatment Sequencing Impact on Outcomes and Costs in Relapsed/Refractory FL

11/30/2020

Journal of Clinical Pathways

Videos

Study Highlights Need to Minimize Health Care Costs in FL

11/29/2020

Nathan Fowler, MD, MD Anderson Cancer Center, discusses results from a study which explored treatment patterns and health care costs in commercially insured patients with FL.

Nathan Fowler, MD, MD Anderson...

11/29/2020

Journal of Clinical Pathways

News

Darolutamide for Castration-Resistant Prostate Cancer Results in 5-Year Cost Savings

11/25/2020

Journal of Clinical Pathways